TB-500: Thymosin Beta-4
Regeneration vs degeneration — where this fits
The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.
This topic: TB-500 (thymosin beta-4) is studied for repair-cell migration and actin regulation — cells that need to reach an injury and rebuild structure. That is regeneration: move repair machinery to the damage.
What it is
2025 study on Tβ4's role in vascular injury repair via interaction with CCN5. Tβ4 promotes cell migration, angiogenesis, and modulates inflammation via actin sequestration.
How it works
Step logic:
- 2025 study on Tβ4's role in vascular injury repair via interaction with CCN5.
- Tβ4 promotes cell migration, angiogenesis, and modulates inflammation via actin sequestration.
- The claim that Tβ4 production declines approximately 60% by age 60 is not supported by the provided sources and lacks specific data to back up the assertion.
- New 2025 PubMed study on engineered tandem TB4 peptide for corneal healing, building on TB-500/TB4 research.
- Analysis of commercial TB500 products showing inconsistencies and adulteration.
- 2025 PubMed article on TB4 effects in cardiac remodeling and repair.
- The quality and consistency of commercially available TB-500 products are a concern, with some analyses indicating inconsistencies and adulteration.
- 2024 study showing Tβ4 promotes axon regeneration, relevant to tissue repair mechanisms.
Why it would work (logic chain)
- IF 2025 study on Tβ4's role in vascular injury repair via interaction with CCN5. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
- IF Tβ4 promotes cell migration, angiogenesis, and modulates inflammation via actin sequestration. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
- IF The claim that Tβ4 production declines approximately 60% by age 60 is not supported by the provided sources and lacks specific data to back up the assertion. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
- IF New 2025 PubMed study on engineered tandem TB4 peptide for corneal healing, building on TB-500/TB4 research. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
- IF Analysis of commercial TB500 products showing inconsistencies and adulteration. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
- IF 2025 PubMed article on TB4 effects in cardiac remodeling and repair. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
Why people take it
Reasons that appear in this ledger:
- User reports elbow injury (muscle/tendon from bench) healed after 3 weeks of TB-500 + BPC stack; good outcome.
- User reports long-standing shoulder injury healed with TB-500 + BPC; positive user experience for muscle repair.
- Mixed outcome: helps minor strains and inflammation but possible side effect of lipoma growth; not life-changing.
- Discussion of TB-500/Thymosin Beta-4 for healing, part of Wolverine Stack anecdotes implied in biohacking context. Not advice.
- Anecdotal positive outcome: TB-500 + BPC-157 for systemic tissue repair and reduced inflammation; no dosing details.
- X post with anecdotal dosing (500mcg each 3x/week) for chronic pain/old injuries using TB-500 + BPC-157 combo (anecdotal, not advice).
- Anecdotal report of side effects including joint and muscle pain from (contextual) peptide use involving TB-500. Bad outcome/side effect anecdote. (anecdotal, not advice).
- Anecdotal mention of TB-500 for faster soft tissue and muscle recovery (anecdotal, not advice).
- Anecdotal user report on using TB-500 (with BPC-157) for meniscus injury recovery.
- User anecdote on using BPC-157 + TB-500 post-ACLR surgery for recovery support.
How many people take it
There is no reliable global count of how many people take this compound. That number is not in this ledger.
What we can count from this ledger:
- 73 anecdote source(s) (posts, threads, comments)
- 74 anecdote-tier claim(s) derived from them
Logic: 73 online report(s) are catalogued here. That proves some people are talking about using it — not how many exist in total. Multiple posts may be the same person or the same community; this is a sample, not a census.
Evidence inventory
This is a count of what is in this ledger — not a claim about all research worldwide.
- Scientific sources catalogued (PubMed, trials, reviews): 25
- Claims tagged human evidence: 14
- Claims tagged preclinical (animal/lab): 4
- Claims tagged anecdotal: 74
- Reddit posts catalogued: 48
- X posts catalogued: 21
- Other anecdote sources (YouTube, Instagram, etc.): 4
- Total sources in chain: 98
Quantified confidence (this ledger): 0.95 / 1.00 — moderate — human claims present in ledger
Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.
What scientists say
Thymosin β4: a multi-functional regenerative peptide (source s1)
Review of Tβ4 biology and potential clinical uses in repair.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
Thymosin beta4 accelerates wound healing (source s2)
Rat wound healing study.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers (source s3)
Phase 1 human safety data.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
The Regenerative Peptide Thymosin β4 Accelerates the Rate of Dermal Healing (source s4)
Human Phase 2 wound healing results.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
Therapeutic Peptides in Orthopaedics: Applications, ... (source s5)
2026 review discussing TB-500 in orthopaedic wound healing and tissue repair.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
Injectable Peptide Therapy: A Primer for Orthopaedic and ... (source s6)
2026 review on peptides including TB-500, noting preclinical promise but lack of human orthopaedic data.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
Simultaneous quantification of TB-500 and its metabolites ... (source s7)
2024 study on analytical methods for TB-500 and metabolites, with wound healing screening.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
TB500/TB1000 and SGF1000: A scientific approach for a ... (source s8)
Analysis of commercial TB500 products showing inconsistencies and adulteration.
Evidence type: Published research.
Recombinant human thymosin beta 4 improves ischemic ... (source s9)
2025/2026 study on rhTB4 (related to TB-500) for ischemic injury in models.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Thymosin beta 4 as an Alzheimer disease intervention (source s12)
Discusses thymosin beta 4 (Tβ4) expression decrease in Alzheimer's models and patients, suggesting potential intervention role.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
Alkaline Phosphatase-Triggered Spatiotemporal Repair of Corneal Injury with TB500 Peptide Hydrogel (source s13)
First ocular application of TB500 in enzyme-responsive hydrogel for corneal injury repair in preclinical study.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
Thymosin beta 4: An emerging therapeutic candidate for kidney diseases (source s14)
Review on Tβ4 as therapeutic candidate for kidney diseases, focusing on fibrosis, inflammation.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction (source s15)
Ongoing or listed Phase IIa trial of recombinant human thymosin beta 4 for AMI patients.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
Engineered Tandem Thymosin Peptide Promotes Corneal Wound Healing (source s22)
New 2025 PubMed study on engineered tandem TB4 peptide for corneal healing, building on TB-500/TB4 research.
Evidence type: Published research.
Thymosin Beta-4 Modulates Cardiac Remodeling by Promoting Myocardial Cell Survival (source s23)
2025 PubMed article on TB4 effects in cardiac remodeling and repair.
Evidence type: Published research.
A Phase 1a Study of Thymosin Beta 4 in Healthy Volunteers (source s24)
New clinical trial entry for Thymosin Beta 4 safety in healthy volunteers, distinct from listed NCT05485818.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 (source s25)
Additional Thymosin Beta 4 clinical trial not in collected list.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
Thymosin Beta-4 and TB-500 in Tissue Healing and Musculoskeletal Medicine (source s26)
2026 review article specifically on TB4 and TB-500 for healing.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
What people say on Reddit
BPC-157, TB-500, and The Wolverine Stack Explained — Reddit, r/ScienceBioTechnology (source s10)
Reddit discussion on TB-500 mechanism for tissue regeneration based on preclinical data.
Any experience with muscle/tissue repair? Tb-500? — Reddit, r/AskMenOver30 (source s11)
Anecdotal user report on using TB-500 (with BPC-157) for meniscus injury recovery.
Documenting My ACLR + Meniscus Repair Journey – Trying the “Wolverine Stack” (BPC-157 + TB-500) — Reddit, r/ACL (source s16)
User anecdote on using BPC-157 + TB-500 post-ACLR surgery for recovery support.
I was hospitalised after running TB-500 — Reddit, r/PeptidePathways (source s18)
User reports severe allergic reaction (hives, throat swelling) leading to hospitalization after using TB-500 (continued after stopping BPC), bad outcome.
Strange side effects of BPC 157 and TB 500 — Reddit, r/bpc_157 (source s19)
Post discussing strange side effects from BPC-157 + TB-500 combination, user-reported experiences (mixed/good/bad implied in thread).
Thymosin Beta 4: Genetics & Supplemental Peptides — Reddit, r/geneticlifehacks (source s27)
Recent Reddit anecdote/discussion on TB-500 and TB4 supplementation and genetics.
BPC 157 & TB500 -experience ? — Reddit, r/ACL (source s28)
User anecdote on TB-500 + BPC-157 for ACL recovery.
Healing Compounds - BPC-157, TB-500 — Reddit, r/steroids (source s36)
User reports total success with TB-500 combo for healing after 8 weeks.
BPC-157 and TB-500 Therapy Log — Reddit, r/PlantarFasciitis (source s37)
Positive drastic healing reported for plantar fasciitis with TB-500/BPC combo.
My experience with TB500/BPC157 — Reddit, r/Biohackers (source s38)
User describes near-complete knee pain resolution and 95% improvement with TB-500/BPC-157.
Meniscus Tear and BPC 157 TB500 — Reddit, r/MeniscusInjuries (source s39)
User reports rapid pain relief, muscle rebuilding, and 80% healing of meniscus injury with TB-500/BPC.
BPC-157 and TB-500 no results after 6 weeks — Reddit, r/bpc_157 (source s40)
User reports no noticeable relief or results after weeks of TB-500/BPC-157 use.
Thoughts on BPC-157? — Reddit, r/crossfit (source s41)
User reports significant pain reduction in what seems to be a muscle/tendon issue after adding TB-500 to regimen; attributes possible healing benefit.
Thoughts on BPC-157? — Reddit, r/crossfit (source s42)
User confirms best healing results from combining with TB-500 for injury recovery.
Experience with BPC-157 and Elbow Tendinopathy — Reddit, r/climbharder (source s43)
User reports TB-500 (with BPC) cured elbow tendonitis in 4-6 weeks; positive outcome for soft tissue repair.
BPC157/TB500 to heal TFCC tear? — Reddit, r/bpc_157 (source s44)
User reports combo sped up healing of persistent pain/TFCC issues alongside meniscus treatment.
What people say on X
X post by TylerD — X (source s45)
User reports elbow injury (muscle/tendon from bench) healed after 3 weeks of TB-500 + BPC stack; good outcome.
X post by The Dad Experiment — X (source s46)
User reports long-standing shoulder injury healed with TB-500 + BPC; positive user experience for muscle repair.
X post on TB-500 experiences — X (source s51)
Mixed outcome: helps minor strains and inflammation but possible side effect of lipoma growth; not life-changing.
X post on BPC-157 and TB-500 — X (source s59)
Discussion of TB-500/Thymosin Beta-4 for healing, part of Wolverine Stack anecdotes implied in biohacking context. Not advice.
X post distinguishing TB-500 and Thymosin Beta-4 — X (source s60)
Clarification on TB-500 as fragment of Thymosin Beta-4, relevant to muscle repair research. Not advice.
Post about TB-500 — X (source s65)
Anecdotal positive outcome: TB-500 + BPC-157 for systemic tissue repair and reduced inflammation; no dosing details.
Post about TB-500 and BPC-157 — X (source s66)
Anecdotal recommendation for stacking TB-500 (thymosin beta-4 fragment) with BPC for muscle/tissue repair via complementary pathways.
KLOW blend post on TB-500 role in repair — X (source s70)
X post explaining TB-500 (thymosin beta-4) for cell migration and tissue repair; dosing and stacking anecdotes (anecdotal, not advice).
Pairing BPC with TB500 for pain/injuries — X (source s73)
X post with anecdotal dosing (500mcg each 3x/week) for chronic pain/old injuries using TB-500 + BPC-157 combo (anecdotal, not advice).
BowTiedYukon post on TB-500 — X (source s78)
Anecdotal discussion of TB-500 (thymosin beta-4) for muscle repair and tissue healing (anecdotal, not advice).
morellifit on BPC-157 + TB-500 — X (source s79)
Positive anecdotal outcome for muscle regeneration and inflammation reduction with TB-500 stack (anecdotal, not advice).
APeptides on Wolverine Stack — X (source s80)
Anecdotal mention of TB-500 for tissue repair in recovery protocols (anecdotal, not advice).
lawyerschiff on TB-500 — X (source s81)
Anecdotal benefits for cell migration and inflammation in repair (anecdotal, not advice).
BowTiedYukon on TB500 stock — X (source s82)
Discussion of TB-500 promoting tissue and muscle repair (anecdotal, not advice).
Giotraining on Wolverine Stack — X (source s83)
Anecdotal use in recovery protocols for tissue repair (anecdotal, not advice).
How TB-500 Works post — X (source s88)
Detailed explanation of TB-500 mechanisms for muscle/tendon repair, cell migration, angiogenesis, and reducing scar tissue/fibrosis. (informational).
Other anecdote evidence
What Science ACTUALLY Says About TB 500 Benefits — YouTube (source s17)
Video reviewing scientific evidence on TB-500 for injury recovery, referencing PubMed studies.
I Took The Wolverine Stack & My Thoughts On BPC-157 & TB-500 — YouTube (source s20)
Chiropractor shares personal positive experience with BPC-157 + TB-500 for stubborn injury: faster healing, less inflammation and flare-ups (with rehab), some injection site tenderness noted.
TB-500 for Injury Recovery – Does it Work and is it Safe? — YouTube (source s21)
YouTube comments include user reports of rapid pain relief from TB-500 + BPC-157 injections (good outcome); others mention rotator cuff improvement in ~1-2 weeks.
TB-500 (Thymosin Beta 4) Benefits & Risks — YouTube (source s52)
Anecdotal report of rapid healing of rotator cuff and other injuries with TB-500 + BPC-157 stack.
What we do not know
- The quality and consistency of commercially available TB-500 products are a concern, with some analyses indicating inconsistencies and adulteration.
- The results of the ongoing or listed Phase IIa trial investigating recombinant human thymosin beta 4 for acute myocardial infarction (AMI) patients are not yet publicly available.
Safety and limits
- 2025 study on Tβ4's role in vascular injury repair via interaction with CCN5.
---
Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.
Evidence ledger 100 · tier-ranked · API
94 more ranked claims
Low-confidence / auto-generated 1
Ask this article · 8 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.